Scholar Rock Holding (SRRK) Other Working Capital Changes (2017 - 2026)
Scholar Rock Holding's quarterly Other Working Capital Changes came in at -$1.4 million in Q1 2026, up 8.56% year-on-year from -$1.3 million in Q1 2025, and down 117.57% quarter-over-quarter from $8.2 million in Q4 2025.
Scholar Rock Holding has reported Other Working Capital Changes for 10 years, with the latest figure at -$1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 8.56% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (up 148.69% YoY), and the FY2025 full-year result was $3.7 million, up 158.95% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$1.4 million, down from $8.2 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $33.0 million in Q2 2022, with the low at -$33.2 million in Q1 2022.
- Average Other Working Capital Changes over 5 years is -$938470.6, with a median of -$1.4 million recorded in 2026.
- Peak annual rise in Other Working Capital Changes reached 637.79% in 2025, while the deepest fall reached 7614.29% in 2025.
- Tracing SRRK's Other Working Capital Changes over 5 years: stood at $25.8 million in 2022, then sank by 93.85% to $1.6 million in 2023, then slumped by 196.22% to -$1.5 million in 2024, then soared by 637.79% to $8.2 million in 2025, then slumped by 117.57% to -$1.4 million in 2026.
- The last three Other Working Capital Changes figures came in at -$1.4 million (Q1 2026), $8.2 million (Q4 2025), and -$4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.44 Mn |
| Mar 31, 2026 | -1.44 Mn |
| Dec 31, 2025 | 8.21 Mn |
| Dec 31, 2025 | 8.21 Mn |
| Sep 30, 2025 | -4.57 Mn |
| Sep 30, 2025 | -4.57 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | -1.53 Mn |
| Dec 31, 2024 | -1.53 Mn |
| Sep 30, 2024 | -5.27 Mn |
| Sep 30, 2024 | -5.27 Mn |
| Jun 30, 2024 | 505,000.00 |
| Jun 30, 2024 | 505,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 1.59 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | -1.97 Mn |
| Sep 30, 2023 | -1.97 Mn |
| Jun 30, 2023 | -3.37 Mn |
| Jun 30, 2023 | -3.37 Mn |
| Mar 31, 2023 | -773,000.00 |
| Mar 31, 2023 | -773,000.00 |
| Dec 31, 2022 | 25.79 Mn |
| Dec 31, 2022 | 25.79 Mn |
| Sep 30, 2022 | -32.96 Mn |
| Sep 30, 2022 | -32.96 Mn |
| Jun 30, 2022 | 32.96 Mn |
| Jun 30, 2022 | 32.96 Mn |
| Mar 31, 2022 | -33.19 Mn |
| Mar 31, 2022 | -33.19 Mn |
| Dec 31, 2021 | -19.04 Mn |
| Dec 31, 2021 | -19.04 Mn |
| Sep 30, 2021 | 9.53 Mn |
| Sep 30, 2021 | 9.53 Mn |
| Jun 30, 2021 | -7.84 Mn |
| Jun 30, 2021 | -7.84 Mn |
| Mar 31, 2021 | -1.47 Mn |
| Mar 31, 2021 | -1.47 Mn |
| Dec 31, 2020 | -19.60 Mn |
| Dec 31, 2020 | -19.60 Mn |
| Sep 30, 2020 | 2.91 Mn |
| Sep 30, 2020 | 2.91 Mn |
| Jun 30, 2020 | 486,000.00 |
| Jun 30, 2020 | 486,000.00 |
| Mar 31, 2020 | 806,000.00 |
| Mar 31, 2020 | 806,000.00 |
| Dec 31, 2019 | -1.06 Mn |
| Dec 31, 2019 | -1.06 Mn |
| Sep 30, 2019 | 1.06 Mn |
| Sep 30, 2019 | 1.06 Mn |
| Jun 30, 2019 | 3.05 Mn |
| Jun 30, 2019 | 3.05 Mn |
| Mar 31, 2019 | -3.11 Mn |
| Mar 31, 2019 | -3.11 Mn |
| Dec 31, 2018 | -1.00 Mn |
| Dec 31, 2018 | -1.00 Mn |
| Sep 30, 2018 | 355,000.00 |
| Sep 30, 2018 | 355,000.00 |
| Jun 30, 2018 | 720,000.00 |
| Jun 30, 2018 | 720,000.00 |
| Mar 31, 2018 | 33,000.00 |
| Mar 31, 2018 | 33,000.00 |
| Dec 31, 2017 | -1.66 Mn |
| Dec 31, 2017 | -1.66 Mn |
| Sep 30, 2017 | 1.25 Mn |
| Sep 30, 2017 | 1.25 Mn |